Nasdaq Composite & Eli Lilly and Company
11 shared events · Importance 4 · Last updated Jun 30, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Domestic
Nasdaq Composite: The Nasdaq Composite gained, reflecting positive performance in technology and growth stocks, particularly those related to AI.
Eli Lilly and Company: Eli Lilly and Company rose after the United States — Food and Drug Administration approved its new weight loss pill, Foundayo.
Apr 01, 2026 · 14 articles
Business
Nasdaq Composite: The Nasdaq Composite rallied to a new record, primarily driven by the strong performance of technology stocks and the AI boom, highlighting the significant impact of the tech sector on the U.S. market.
Eli Lilly and Company: Eli Lilly and Company>>> advanced after positive trial results for its next-generation obesity drug, retatrutide, which showed benefits beyond weight loss.
May 20, 2026 · 72 articles
Business
Nasdaq Composite: Led market lower with a 2% slide; heavily weighted with AI stocks.
Eli Lilly and Company: Eli Lilly's stock jumped after a committee of the European Medicines Agency recommended one of its medicines for approval, boosting its market performance.
Apr 20, 2026 · 344 articles
International
Nasdaq Composite: The Nasdaq Composite rose, contributing to the overall positive market sentiment driven by hopes for a U.S.-Iran ceasefire extension and AI-related capital expenditure.
Eli Lilly and Company: Eli Lilly and Company>>> advanced after CVS Health>>> announced it would restore coverage for its weight-loss injection, Zepbound, and add its new obesity pill Foundayo.
May 18, 2026 · 309 articles
International
Nasdaq Composite: The Nasdaq Composite rose, contributing to the overall positive market sentiment driven by hopes for a U.S.-Iran ceasefire extension and AI-related capital expenditure.
Eli Lilly and Company: Eli Lilly and Company>>> advanced after CVS Health>>> announced it would restore coverage for its weight-loss injection, Zepbound, and add its new obesity pill Foundayo.
May 27, 2026 · 101 articles
Domestic
Nasdaq Composite: The Nasdaq Composite fell due to weakness in AI-related stocks, suggesting a more cautious sentiment in the technology sector.
Eli Lilly and Company: Eli Lilly and Company saw gains that helped offset drops in other sectors, contributing to the overall positive market performance.
Dec 11, 2025 · 7 articles
International
Nasdaq Composite: The Nasdaq fell due to tech stock declines, but it is less directly tied to the Hormuz situation.
Eli Lilly and Company: Eli Lilly and Company raised its forecast, boosting healthcare stocks. It is not connected to the event.
Mar 09, 2018 · 316 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Nasdaq Composite and Eli Lilly and Company interact across events, view sentiment trends, and discover connected entities.
Open Dashboard